Schedule 13D ownership disclosure
NEOLEUKIN THERAPEUTICS INC
Security class unavailable · CUSIP: 64049K104
Event date: 2023-07-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-084840
- Form type
- SC 13D
- Filer
- Neurogene Inc.
- CIK
- CIK 1404644
- Filed
- Jul 27, 2023
- Reporting period
- Jul 17, 2023
- Description
- Schedule 13D beneficial ownership